PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Peli BioThermal Opens Network Station & Service Centre in Crossroads of America

Peli BioThermal, the global name in temperature controlled packaging, announces the opening of a new network station and service centre in Indianapolis. The facility...
Continue Reading →
News

PCI Pharma Services Announces Agreement to Acquire Sherpa Clinical Packaging

PCI Expands Clinical Services’ presence with acquisition of California-based Sherpa Clinical Packaging Philadelphia, USA – September 10, 2018 Leading gl...
Continue Reading →
News

Zenith Technologies Launches 24/7 Life Science Manufacturing IT Service

Zenith Technologies, a world leader in delivering GMP manufacturing software solutions to the life sciences industry, has launched and rolled out a global 24/7 manuf...
Continue Reading →
News

WuXi AppTec Partner Hutchison MediPharma Receives Approval of Fruquintinib Capsules in China

WuXi AppTec congratulates its partner Hutchison MediPharma (HMP) on receiving approval of fruquintinib capsules (Elunate®) for metastatic colorectal cancer from the ...
Continue Reading →
News

AstraZeneca’s Tagrisso Approved In Japan For EGFR-Mutated NSCLC

UK-based pharmaceutical company AstraZeneca has announced that its Tagrisso (osimertinib) has been approved by the Japanese Ministry of Health, Labour and Welfare fo...
Continue Reading →
News

Pfizer Reports Data From Tafamidis’ Rare Heart Disease Trial

A new phase III clinical trial has demonstrated that Pfizer’s tafamidis drug can lower the risk of death in patients suffering from rare heart condition transthyreti...
Continue Reading →
News

A Study Supported By AstraZeneca Reveal Constant Risk Of CV Events And Death

Findings from three real-world evidence clinical studies supported by AstraZeneca have indicated the need for better secondary prevention of long-term ischemic risk ...
Continue Reading →
News

Janssen bags new EU approval for Darzalex

Janssen’s Darzalex has been approved in Europe for the first-line treatment of patients with multiple myeloma. In 2015, the drug became the first CD38-directed ...
Continue Reading →
News

Another next-gen diabetes research deal for Novo

Novo to work with Ossianix on blood brain barrier drugs Novo Nordisk is continuing with its investments into next generation diabetes and metabolic disease ther...
Continue Reading →
News

Sanofi gets EU OK for Ablynx flagship drug Cablivi

Sanofi has EMA approval for its acquired thrombotic thrombocytopenic purpura (aTTP) therapy Cablivi, the main asset behind its €9.3bn acquisition of Belgian bi...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026